Caption Management, LLC Vaxcyte, Inc. Put Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $1.52 Million - $2.52 Million	21,500 Added 95.56%	44,000 $5.02 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $1.35 Million - $1.77 Million	22,500 New	22,500 $1.7 Million
Q1 2023 May 15, 2023	SELL	$36.27 - $47.2 $1.81 Million - $2.36 Million	-50,000 Reduced 45.45%	60,000 $2.25 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $2.26 Million - $5.27 Million	110,000 New	110,000 $5.27 Million

352

122M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.25B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.